SpectraCure AB (publ) engages in the development of cancer treatment system. It develops Q-PRO, a laser device; and IDOSE software with interstitial photodynamic therapy system for the treatment of prostate cancer. The company was incorporated in 2003 and is based in Lund, Sweden.
Stock data | 2024 | Change |
---|---|---|
Price | $0.2243228681980702 | N/A |
Market Cap | $21.79M | N/A |
Shares Outstanding | 97.13M | N/A |
Employees | 13.00 | N/A |